Eckert & Ziegler Strahlen- Und Medizintechnik AG (EUZ) | Finanzwire

Basculer en Français

8305	Companies
115226	Keywords
55530	Articles
62575	Press releases

Headlines Articles Press releases Eckert & Ziegler Strahlen- Und Medizintechnik AG

Home
Companies
Eckert & Ziegler Strahlen- Und Medizintechnik AG

BRIEF

published on 05/14/2024 at 07:55, 6 months 8 days ago

Eckert & Ziegler Reports Strong Q1 2024 Financial Growth

Financial Growth Q1 2024 Earnings Eckert & Ziegler SE Sales Forecast 2024 Medical Segment Sales
PRESS RELEASE

published on 05/14/2024 at 07:50, 6 months 8 days ago

Eckert & Ziegler with significant increase in sales (+17%) and adjusted EBIT (+41%) in Q1. Forecast 2024 confirmed.
Eckert & Ziegler SE reports strong Q1 results with 17% sales increase and 41% rise in adjusted EBIT. Forecast for 2024 confirmed. Read more: https://www.ezag.com/fileadmin/user_upload/ezag/investors-financial-reports/englisch/euz124e.pdf

Adjusted EBIT Sales Increase 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 04/22/2024 at 14:54, 6 months 29 days ago

Eckert & Ziegler: Boost in Q1 Sales and Earnings, 2024 Forecasts Unchanged

Sales Increase 2024 Forecast EBIT Growth Eckert & Ziegler SE Q1 Financial Results
PRESS RELEASE

published on 04/22/2024 at 14:49, 6 months 29 days ago

EQS-Adhoc: Eckert & Ziegler: Q1 with Significant Increase in Sales and Earnings Compared to Previous year. 2024 Annual Forecast Confirmed.
Eckert & Ziegler SE reports strong Q1 results with sales of EUR 67.6 million and net income of EUR 8.5 million. 2024 annual forecast confirmed

Sales Earnings 2024 Forecast Q1 Results Eckert & Ziegler SE
BRIEF

published on 03/22/2024 at 07:50, 8 months ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023

2023 Financial Year Eckert & Ziegler Annual Results Financial Growth Radiopharmaceuticals
PRESS RELEASE

published on 03/22/2024 at 07:45, 8 months ago

Eckert & Ziegler Continues on Growth Path after Successful Financial Year 2023
Eckert & Ziegler SE reports sales growth in 2023 financial year, with sales reaching €246.1 million. Expecting sales of nearly €265 million in 2024

Sales Growth EBIT Financial Year 2023 Eckert & Ziegler SE Radiopharmaceuticals
BRIEF

published on 03/21/2024 at 10:05, 8 months 1 day ago

Eckert & Ziegler Achieves Key Milestone with MDR Certification for Prostate Seeds

Eckert & Ziegler Patient Safety MDR Certification Prostate Seeds Brachytherapy
PRESS RELEASE

published on 03/21/2024 at 10:00, 8 months 1 day ago

Eckert & Ziegler Receives MDR Certification for Prostate Seeds, Paving the Way for Long-term Supply
Eckert & Ziegler BEBIG GmbH, a subsidiary of Eckert & Ziegler SE, obtains MDR certification for proprietary prostate seeds from DEKRA Certification B.V., ensuring patient safety and long-term supply within the EU

DEKRA Certification Eckert & Ziegler MDR Certification Prostate Seeds Brachytherapy
BRIEF

published on 03/19/2024 at 19:51, 8 months 2 days ago

Eckert & Ziegler Announces Dividend Cut to Fund Future Investments

Investment Eckert & Ziegler Financial Forecast Dividend Reduction Radiopharmaceuticals
PRESS RELEASE

published on 03/19/2024 at 19:46, 8 months 2 days ago

EQS-Adhoc: Eckert & Ziegler Reduces Dividend to Finance Future Investments. Earnings Growth Expected for 2024.
Eckert & Ziegler reduces dividend to fund future investments, aiming for earnings growth in 2024. Details on financial performance and strategic moves disclosed

Financial Performance Eckert & Ziegler Earnings Growth Dividend Reduction Strategic Investments

Accesswire

Published on 11/22/2024 at 09:00, 3 hours 49 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 12 hours 49 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 14 hours 44 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 14 hours 59 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 16 hours 34 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 11:54, 55 minutes ago

PIERER Mobility denies media reports about Mark Mateschitz's participation in PIERER Mobility and KTM
Published on 11/22/2024 at 11:45, 1 hour 4 minutes ago

How 5G Transforms Life: A Foreigner's Journey Through East China's Digital Revolution
Published on 11/22/2024 at 11:21, 1 hour 28 minutes ago

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy
Published on 11/22/2024 at 11:06, 1 hour 43 minutes ago

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research GmbH): BUY
Published on 11/22/2024 at 11:00, 1 hour 49 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 1 day 5 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 17 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 19 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 19 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 2 days 5 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE